Evidence map›Paper›PMID 42964219›Full record

ArticleJournal of clinical medicine research2026

Ectopic Adipose Tissue Depots and Metabolic-Associated Fatty Liver Disease: Relationships With Vitamin D.

Anna Bragina, Yulia Rodionova, Maria Vetluzhskaya, Maria Vasilchenko, Irakli Loriya, Daria Akvitskaya, Sarvar Abduganiev, Olga Belaya, Karina Umbetova, Andrey Gorobchenko and 2 more

Abstract read
In one paragraph

Article in Journal of clinical medicine research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anna BraginaDepartment of Faculty Therapy No. 2, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Yulia RodionovaDepartment of Faculty Therapy No. 2, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Maria VetluzhskayaDepartment of Faculty Therapy No. 2, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Maria VasilchenkoDepartment of Faculty Therapy No. 2, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Irakli LoriyaDepartment of Faculty Therapy No. 2, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Daria AkvitskayaDepartment of Faculty Therapy No. 2, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Sarvar AbduganievDepartment of Faculty Therapy No. 2, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Olga BelayaDepartment of Infectious Diseases, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Karina UmbetovaDepartment of Infectious Diseases, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Andrey GorobchenkoDepartment of Infectious Diseases, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Danila VoevodinDepartment of Faculty Therapy No. 2, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Valeriy PodzolkovDepartment of Faculty Therapy No. 2, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The relationship between vitamin D status, adipose tissue dysfunction and the development of metabolic-associated fatty liver disease (MAFLD) is currently under active investigation. This study aimed to assess the associations of serum vitamin D levels with MAFLD and different ectopic adipose tissue depots, including perivascular adipose tissue (PVAT), epicardial adipose tissue (EAT), and hepatic steatosis, and to determine whether these associations persisted after adjustment for potential confounders. Methods: This cross-sectional study included 303 patients without established atherosclerotic cardiovascular disease (mean age 55 years (40-60)). PVAT was evaluated by measuring the common carotid artery extra-media thickness (CCA EMT) using duplex ultrasound. EAT thickness was assessed by echocardiography. Hepatic steatosis was quantified by measuring the attenuation coefficient (AC) using vibration-controlled transient elastography. Serum 25-OH vitamin D levels were determined using enzyme-linked immunosorbent assay. Patients were stratified into four groups according to serum vitamin D levels. Multivariable logistic and linear regression analyses were performed to account for potential confounders. Results: Hepatic steatosis was detected in 125 (41.3%) patients, and MAFLD was detected in 110 (36.3%). Significant inverse correlations were observed between vitamin D levels and AC (r = -0.238) and MAFLD (r = -0.242) (both P < 0.05). General and abdominal obesity were significantly more prevalent in patients with severe vitamin D deficiency compared with those with vitamin D insufficiency and target levels (50% vs. 26.8% and 23%; 70% vs. 29.3% and 23.1%, respectively; P = 0.001 for both). MAFLD was also significantly more frequent in the severe deficiency group than in the deficiency, insufficiency, and target level groups (80% vs. 31.3%, 34.1%, and 15.4%; P = 0.001). In adjusted analyses, the association between 25(OH)D and MAFLD was attenuated after adjustment for body mass index but remained significant in the model including waist circumference. Compared with patients with target vitamin D levels, those with severe deficiency exhibited greater EAT thickness, CCA EMT, and AC (all P < 0.05). Higher 25(OH)D concentrations were independently associated with lower CCA EMT, AC, and EAT thickness after adjustment for age, sex, and adiposity. Conclusion: Our findings demonstrate associations between vitamin D deficiency, ectopic adipose tissue depots, and MAFLD, suggesting that low vitamin D levels may potentially be linked to adipose tissue dysfunction and cardiometabolic remodeling.

Indexed as

Epicardial adipose tissueExtra-media thicknessMetabolic-associated fatty liver diseasePerivascular adipose tissueVitamin D

Identifiers

PMID42964219
PMCPMC13719649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.